ED Treatment Advertising Compliance in 2026

ED treatment advertising compliance in 2026 is more demanding than it was even two years ago, as platform policies have tightened around men's sexual health advertising in response to a surge of brands in the category and several high-profile compliance failures. The ED telehealth space has produced significant ad spend on Meta and Google, which has made it a priority review category for both platforms. Understanding the current compliance requirements — which differ by platform and have changed materially in recent years — is a prerequisite for scaling in this category without constant ad account disruption.

The ED treatment compliance picture involves three separate sets of requirements: FDA rules for advertising prescription ED medications (sildenafil, tadalafil, vardenafil), platform-specific content policies for sexual health advertising, and FTC requirements for health claims and testimonials. These three sets of rules interact in ways that create specific compliance constraints unique to the ED telehealth category.

Age Targeting Requirements

All three major platforms — Meta, Google, and TikTok — require ED treatment telehealth advertisers to restrict their targeting to adults aged 18 and older. Meta's policies for sexual health advertising specifically require that age targeting be set to exclude minors, and many ED advertisers go further by setting minimum ages of 25 or 30 to align the audience with clinical appropriateness. This age restriction must be implemented in the campaign settings — it is not sufficient to include language in the ad suggesting it is for adults. The platform-level targeting restriction is required independently of creative content.

Beyond the adult targeting requirement, Meta's policies for ED treatment advertising require LegitScript certification for advertisers running prescription medication-adjacent content. This includes ads that name specific prescription ED medications (Viagra, Cialis, sildenafil, tadalafil) and ads that advertise telehealth services where prescription ED medications are a primary or prominent offering. Without LegitScript certification, these ad categories face consistent rejection and account-level flagging.

Claim Language That Triggers Rejection

ED treatment advertising faces two overlapping content restrictions: sexual content policies and health claim policies. Sexual content policies restrict explicit references to sexual performance or sexual activity in ad creative. Health claim policies restrict specific efficacy claims about ED treatment outcomes. The intersection creates a narrow band of acceptable language that takes experience in the category to navigate effectively.

Claims that trigger sexual content rejections include: explicit references to sexual intercourse, language that could be interpreted as promoting sexual performance enhancement in a graphic way, and imagery that implies sexual activity. Claims that trigger health policy rejections include: specific success rate promises for ED treatment, before-and-after language applied to sexual performance, and disease treatment claims ("treats ED," "cures erectile dysfunction"). The language that passes review consistently focuses on the medical consultation — access to a licensed provider, convenient online evaluation — without making explicit sexual performance claims or specific efficacy promises. See our guide to advertising ED treatment on Facebook for detailed copy examples.

Compounded ED Medications and Additional Rules

Many ED telehealth brands offer compounded ED medications — including compounded tadalafil, compounded sildenafil, and combination compounds like sildenafil-tadalafil formulations. The compounded medication advertising rules discussed elsewhere in this compliance series apply in full to compounded ED medications. Advertisers cannot claim that compounded ED medications are equivalent to brand-name Viagra or Cialis, cannot borrow the clinical trial substantiation from the branded drugs for claims about the compounded versions, and must make clear that compounded medications are not FDA-approved.

Compounded ED medications also face the general compounded medication platform review challenges — the same ambiguity about how platform policies apply to non-FDA-approved prescription preparations. Compounded ED medication advertising has historically had a higher rejection rate on Meta than branded medication-adjacent ED advertising because the platform's review system handles the compounded medication category less consistently. Building an advertising approach around the telehealth service rather than the specific compounded product reduces this variability.

TikTok and ED Treatment Advertising

TikTok presents particular compliance challenges for ED treatment advertisers because its content policies around sexual health are stricter and more uniformly enforced than Meta's. TikTok prohibits sexually suggestive content in advertising more broadly than Meta, which narrows the creative space for ED treatment ads significantly. ED telehealth brands running on TikTok find success with creative that focuses entirely on men's health broadly — energy, confidence, vitality — without any explicit reference to sexual function or ED as a condition.

This broad men's health framing works on TikTok because the platform's algorithm is effective at serving men's health advertising to men who are likely to be interested in the category — sexual health, confidence, and vitality are closely associated interests for the male demographic that represents the ED telehealth patient population. The creative does not need to explicitly name ED to reach the relevant audience on TikTok. The conversion funnel does the more specific work on the landing page, where the content policies that apply to advertising do not apply in the same way.

FTC Requirements for ED Telehealth Testimonials

ED treatment testimonials are among the most sensitive in telehealth advertising because they involve claims about sexual health and performance — a category where individual variation is high and where the placebo effect is significant. A patient testimonial claiming dramatic improvement in sexual performance after ED treatment may be genuine — but it may also reflect the placebo effect, lifestyle changes, or psychological factors that have nothing to do with the specific medication. The FTC's requirement to disclose typical results applies with particular force in this context.

ED testimonials that focus on confidence, the quality of the healthcare experience, or the ease of the telehealth process rather than specific sexual performance outcomes face fewer FTC compliance challenges than testimonials that directly address sexual performance improvement. Reframing ED testimonial content toward the treatment experience — the ease of the consultation, the comfort of privacy, the professionalism of the provider — avoids the sexual content policy and reduces the FTC compliance burden simultaneously. Review the testimonial rules for telehealth ads for the full framework.

Building a Sustainable ED Telehealth Creative System

The ED telehealth brands that run the most stable advertising programs in 2026 are the ones that have built creative systems around the compliance requirements rather than constantly testing the boundaries. They maintain a core library of compliant creative formats — consultation access messaging, men's health lifestyle content, provider quality messaging — that runs consistently without rejection. They test edgier creative formats in small batches to identify what the platforms currently allow, but they do not make their core campaign depend on borderline content that may be rejected or flagged.

This disciplined approach to creative testing prevents the account health deterioration that comes from high rejection rates, and it builds an institutional knowledge base about what works in the category. The brands that treat ED advertising compliance as a constraint to design around — rather than a problem to solve once and forget — are the ones that sustain strong patient acquisition at scale over multiple years. See our guide to compliant claims in telehealth advertising for the full compliance framework that applies to men's health telehealth.